Keywords: collaborations, boost, revenues, ligand, company, pharmaceuticals, achieved
Collaborations Boost Revenues At Ligand
Article | 02 September 1996
US company Ligand Pharmaceuticals achieved revenues in the second quarter of 1996 of $8.5 million, up 57.4%. In the six-month period revenues advanced 73% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
